Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMWZO21)

Drug Name	FP-187 DMWZO21

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Secondary progressive multiple sclerosis	DISAJTO1	N.A.	Approved	[1]
Multiple sclerosis	DISB2WZI	8A40	Approved	[1]
------------------------------------------------------------------------------------

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Autoimmune diabetes	DISW6UF1	5A10	Investigative	[2]
------------------------------------------------------------------------------------

References

1	A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
2	ClinicalTrials.gov (NCT01230138) Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis. U.S. National Institutes of Health.